Open AccessIncident HPV 51 Infection after Prophylactic Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine Gardasil/Silgard®
Author(s) -
Philippe Halfon,
Sophie Ravet,
Hacène Khiri,
Guillaume Pénaranda,
Carole Lefoll
Publication year - 2010
Publication title -
clinical medicine insights case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.187
H-Index - 12
ISSN - 1179-5476
DOI - 10.4137/ccrep.s6177
Subject(s) - gardasil , medicine , human papillomavirus , virology , vaccination , cervical cancer , cancer
We report the case of a 19-year-old woman who received a complete vaccine program by Gardasil. After one year, Greiner HPV test revealed HPV51 positivity. This case report highlights the limits of the vaccine, and the need to have a clinical follow up of patients despite the vaccination program.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom